Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

The Breakthrough That is Giving Patients a Second Chance

In what researchers are calling the biggest leap in decades, a new clinical trial has shown that the immunotherapy drug pembrolizumab can nearly double the time head and neck cancer patients remain cancer-free. The study followed over 700 patients across 24 countries and found that those treated with the drug before standard surgery and radiation stayed cancer-free for an average of five years—far longer than the current average of 30 months. The drug works by supercharging the immune system to fight off cancer cells, and it proved effective across all patient types, even those without high immune markers.

For many, this isn’t just another treatment, it’s a second chance at life. Laura Marston, once diagnosed with stage 4 tongue cancer, now remains disease-free six years after starting the trial. Experts say the results could change how doctors approach early-stage and locally advanced cancers, offering hope to thousands. Some patients are even outliving the expected averages, giving researchers more reason to be optimistic about immunotherapy’s future.

PrevPreviousThey Thought This Gecko Was Gone Forever
NextA Surprising Solution to the Global Water CrisisNext

Recent Articles

Happy News

This Drug Enters Cancer Cells 12.5x Faster With NO Side Effects

November 6, 2025

Researchers at Northwestern University have completely reimagined a classic chemotherapy drug using nanotechnology, transforming a weak, poorly soluble compound into a precision cancer therapy that is up to 20,000 times more effective at destroying cancer cells. The scientists created the drug entirely from scratch as a spherical nucleic acid, a

Read More
Happy News

Diagnosed At 11 And He’s CHANGING Cancer Research

November 6, 2025

Sam Taylor was just 11 years old when he went to the emergency room for an MRI and received a devastating diagnosis: a low grade optic glioma, a brain tumor in the optic pathway that accounts for only five percent of all childhood brain tumors. The surgeon initially planned to

Read More
Happy News

She Couldn’t Invite Them All So They Brought Wedding To HER

November 6, 2025

Brianna Lanoye, principal of Buffalo Academy of Science in New York, kept telling everyone she wished she could invite her entire K through 12 school to her wedding, mentioning it so many times that her school family decided to make it happen in the most unexpected way. Just days before

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2025 HappyNews.